Proteinase inhibitors and helminth parasite infection

Parasite Immunology

Volumn 29, Issue 2, 2007, Pages 57-71

  Knox, D P ^a  

^a MOREDUN RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Anticoagulant; Aspin; Cystatin; Immunomodulation; Inhibitor; Nematode; Proteinase; Serpin; TIMP

Indexed keywords

ALPHA 2 MACROGLOBULIN; ANTIFILARIAL AGENT; APROTININ; ASPARTIC PROTEINASE INHIBITOR; CATHEPSIN B; CATHEPSIN D; CATHEPSIN E; CATHEPSIN G; CHYMASE; COMPLEMENTARY DNA; CYSTATIN; CYSTEINE PROTEINASE INHIBITOR; GAMMA INTERFERON; HYBRID PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; METALLOPROTEINASE INHIBITOR; PROTEINASE INHIBITOR; RECOMBINANT ASPIN; RECOMBINANT TISSUE INHIBITOR OF METALLOPROTEINASE; SERINE PROTEINASE INHIBITOR; TAENIASTATIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TOXOPLASMA GONDII VACCINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VACCINE;

AMINO ACID SEQUENCE; ASCARIS SUUM; BRUGIA MALAYI; CAENORHABDITIS ELEGANS; CHEMOTAXIS; CYTOKINE PRODUCTION; DOG; DRUG POTENCY; DRUG TARGETING; EXPERIMENTAL MOUSE; FILARIASIS; GASTROINTESTINAL INFECTION; GENE IDENTIFICATION; HELMINTH; HELMINTHIASIS; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; INFECTION SENSITIVITY; INNATE IMMUNITY; LEISHMANIA MAJOR; MAMMAL; MOLECULAR INTERACTION; MONOCYTE; NEMATODE; NEUTROPHIL; NONHUMAN; ONCHOCERCA VOLVULUS; PARASITE CONTROL; PARASITE IMMUNITY; PARASITE SURVIVAL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEINASE INHIBITION; RED DEER; REVIEW; SCHISTOSOMA; SEX DIFFERENCE; SEX RATIO; TH1 CELL; TH2 CELL; TRICHOSTRONGYLUS; TRICHURIS; VACCINATION;

ANIMALS; HELMINTH PROTEINS; HOST-PARASITE RELATIONS; HUMANS; NEMATODA; NEMATODE INFECTIONS; PROTEASE INHIBITORS; SERPINS;

VERMES;

EID: 33846274159     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2006.00913.x     Document Type: Review

References (151)

1. Armstrong PB. The contribution of proteinase inhibitors to immune defense. Trends Immunol 2001; 22: 47-52.
2. Tort J, Brindley PJ, Knox DP, Wolfe KH & Dalton JP. Proteinases and associated genes of parasitic helminths. Adv Parasitol 1999; 43: 161-266.
3. Mendel LB & Blood AF. Trypsin, chymotrypsin and pepsin inhibition by extracts of Ascaris lumbricoides. J Biol Chem 1910; 8: 177-181.
4. Hill RE & Hastie ND. Accelerated evolution in the reactive centre regions of serine protease inhibitors. Nature 1987; 326: 96-99.
5. Zang X & Maizels RM. Serine proteinase inhibitors from nematodes and the arms race between host and pathogen. Trends Biochem Sci 2001; 26: 191-197.
6. Leid RW, Suquet CM, Bouwer HG & Hinrichs DJ. Interleukin inhibition by a parasite protease inhibitor, taeniaestatin. J Immunol 1986; 137: 2700-2702.
7. Suquet C, Green-Edwards C & Leid RW. Isolation and partial characterization of a Taenia taeniaeformis metacestode proteinase inhibitor. Int J Parasitol 1984; 14: 165-172.
8. Leid RW, Suquet CM & Tanigoshi L. Parasite defence mechanisms for evasion of host attack: A review. Vet Parasitol 1987, 25: 147-162.
9. Leid RW, Grant RF & Suquet CM. Inhibition of equine neutrophil chemotaxis and chemokinesis by a Taenia taeniaeformis proteinase inhibitor, taeniaestatin. Parasite Immunol 1987; 9: 195-204.
10. Ribeiro JM, Makoul GT, Levine J, Robinson DR & Spielman A. Antihemostatic, antiinflammatory, and immunosuppressive properties of the saliva of a tick, Ixodes dammini. J Exp Med 1985; 161: 332-344.
11. Wikel SK & Whelen AC. Ixodid-host immune interaction. Identification and characterization of relevant antigens and tick-induced host immunosuppression. Vet Parasitol 1986; 20: 149-174.
12. Rawlings ND, Tolle DP & Barrett AJ. Evolutionary families of peptidase inhibitors. Biochem J 2004; 378: 705-716.
13. Kutas J, Kondrak M, Szenthe B et al. Colorado potato beetle larvae on potato plants expressing a locust proteinase inhibitor. Commun Agric Appl Biol Sci 2004; 69: 281-287.
14. McKay TR, Bell S, Tenev T et al. Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy. Oncogene 2003; 22: 3539-3547.
15. Skuce PJ, Newlands GF, Stewart EM et al. Cloning and characterisation of thrombospondin, a novel multidomain glycoprotein found in association with a host protective gut extract from Haemonchus contortus. Mol Biochem Parasitol 2001; 117: 241-244.
16. Hawdon JM, Datu B & Crowell M. Molecular cloning of a novel multidomain Kunitz-type proteinase inhibitor from the hookworm Ancylostoma caninum. J Parasitol 2003; 89: 402-407.
17. Silverman GA, Bird PI, Carrell RW et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem 2001; 276: 33293-33296.
18. Huntington JA, Read RJ & Carrell RW. Structure of a serpin-protease complex shows inhibition by deformation. Nature 2000; 407: 923-926.
19. Miura Y, Kawabata S, Wakamiya Y, Nakamura T & Iwanaga S. A Limulus intracellular coagulation inhibitor type 2. Purification, characterization, cDNA cloning, and tissue localization. J Biol Chem 1995; 270: 558-565.
20. Zhu Y, Wang Y, Gorman MJ, Jiang H & Kanost MR. Manduca sexta serpin-3 regulates prophenoloxidase activation in response to infection by inhibiting prophenoloxidase-activating proteinases. J Biol Chem 2003; 278: 46556-46564.
21. Levashina EA, Langley E, Green C et al. Constitutive activation of toll-mediated antifungal defense in serpin-deficient Drosophila. Science 1999; 285: 1917-1919.
22. Jiang H & Kanost MR. Characterization and functional analysis of 12 naturally occurring reactive site variants of serpin-1 from Manduca sexta. J Biol Chem 1997; 272: 1082-1087.
23. Kruger O, Ladewig J, Koster K & Ragg H. Widespread occurrence of serpin genes with multiple reactive centre-containing exon cassettes in insects and nematodes. Gene 2002; 293: 97-105.
24. MacLennan K, McLean K & Knox DP. Serpin expression in the parasitic stages of Trichostrongylus vitrinus, an ovine intestinal nematode. Parasitol 2005; 130: 349-357.
25. Grasberger BL, Clore GM & Gronenborn AM. High-resolution structure of Ascaris trypsin inhibitor in solution: direct evidence for a pH-induced conformational transition in the reactive site. Structure 1994; 2: 669-678.
26. Duggan BM, Dyson HJ & Wright PE. Inherent flexibility in a potent inhibitor of blood coagulation, recombinant nematode anticoagulant protein c2. Eur J Biochem 1999; 265: 539-548.
27. Zang X, Yazdanbakhsh M, Jiang H, Kanost MR & Maizels RM. A novel serpin expressed by blood-borne microfilariae of the parasitic nematode Brugia malayi inhibits human neutrophil serine proteinases. Blood 1999; 94: 1418-1428.
28. Sottrup-Jensen L, Borth W, Hall M, Quigley JP & Armstrong PB. Sequence similarity between alpha 2-macroglobulin from the horseshoe crab, Limulus polyphemus, and proteins of the alpha 2-macroglobulin family from mammals. Comp Biochem Physiol B 1990; 96: 621-625.
29. Barrett AJ. The cystatins: a diverse superfamily of cysteine peptidase inhibitors. Biomed Biochim Acta 1986; 45: 1363-1374.
30. Abrahamson M. Cystatins. Meth Enzymol 1994; 244: 685-700.
31. Hartmann S & Lucius R. Modulation of host immune responses by nematode cystatins. Int J Parasitol 2003; 33: 1291-1302.
32. Hall A, Dalboge H, Grubb A & Abrahamson M. Importance of the evolutionarily conserved glycine residue in the N-terminal region of human cystatin C (Gly-11) for cysteine endopeptidase inhibition. Biochem J 1993; 291: 123-129.
33. Bjork I, Brieditis I & Abrahamson M. Probing the functional role of the N-terminal region of cystatins by equilibrium and kinetic studies of the binding of Gly-11 variants of recombinant human cystatin C to target proteinases. Biochem J 1995; 306: 513-518.
34. Auerswald EA, Nagler DK, Assfalg-Machleidt I, Stubbs MT, Machleidt W & Fritz H. Hairpin loop mutations of chicken cystatin have different effects on the inhibition of cathepsin B, cathepsin L and papain. FEBS Lett; 361: 179-184.
35. Schierack P, Lucius R, Sonnenburg B, Schilling K & Hartmann S. Parasite-specific immunomodulatory functions of filarial cystatin. Infect Immun 2003; 71: 2422-2429.
36. Manoury B, Gregory WF, Maizels RM & Watts C. Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing. Curr Biol 2001; 11: 447-451.
37. Maizels RM, Balic A, Gomez-Escobar N, Nair M, Taylor MD & Allen JE. Helminth parasites - masters of regulation. Immunol Rev 2004; 201: 89-116.
38. Murray J, Manoury B, Balic A, Watts C & Maizels RM. Bm-CPI-2, a cystatin from Brugia malayi nematode parasites, differs from Caenorhabditis elegans cystatins in a specific site mediating inhibition of the antigen-processing enzyme AEP. Mol Biochem Parasitol 2005; 139: 197-203.
39. Klager SL, Hagen HE & Bradley JE. Effects of an Onchocerca- derived cysteine protease inhibitor on microfilariae in their simuliid vector. Parasitology 1999; 118: 305-310.
40. Martzen MR, McMullen BA, Smith NE, Fujikawa K & Peanasky RJ. Primary structure of the major pepsin inhibitor from the intestinal parasitic nematode Ascaris suum. Biochemistry 1990; 29: 7366-7372.
41. Kageyama T. Molecular cloning, expression and characterization of an Ascaris inhibitor for pepsin and cathepsin E. Eur J Biochem 1998; 253: 804-809.
42. Ng KK, Petersen JF, Cherney MM et al. Structural basis for the inhibition of porcine pepsin by Ascaris pepsin inhibitor-3. Nat Struct Biol 2000; 7: 653-657.
43. Shaw RJ, McNeill MM, Maass DR et al. Identification and characterisation of an aspartyl protease inhibitor homologue as a major allergen of Trichostrongylus colubriformis. Int J Parasitol 2003; 33: 1233-1243.
44. De Maere V, Vercauteren I, Gevaert K, Vercruysse J & Claerebout E. An aspartyl protease inhibitor of Ostertagia ostertagi: molecular cloning, analysis of stage and tissue specific expression and vaccine trial. Mol Biochem Parasitol 2005; 141: 81-88.
45. Chandrashekar R, Ogunrinade AF, Henry RW, Lustigman S & Weil GJ. Onchocerca volvulus: monoclonal antibodies to immune complex-associated parasite antigens. Exp Parasitol 1993; 77: 224-234.
46. Hong XQ, Santiago Mejia J, Kumar S, Perler FB & Carlow CK. Cloning and expression of DiT33 from Dirofilaria immitis: a specific and early marker of heartworm infection. Parasitology 1996; 112: 331-338.
47. Duffy MS, MacAfee N, Burt MD & Appleton JA. An aspartyl protease inhibitor orthologue expressed by Parelaphostrongylus tenuis is immunogenic in an atypical host. Clin Diagn Lab Immunol 2002; 9: 763-770.
48. Willenbucher J, Hofle W & Lucius R. The filarial antigens Av33/Ov33-3 show striking similarities to the major pepsin inhibitor from Ascaris suum. Mol Biochem Parasitol 1993; 57: 349-351.
49. Dissanayake S, Xu M, Nkenfou H & Piessens WF. Molecular cloning and serological characterization of a Brugia malayi pepsin inhibitor homolog. Mol Biochem Parasitol 1993; 62: 143-146.
50. Delaney A, Williamson A, Brand A et al. Cloning and characterisation of an aspartyl protease inhibitor (API-1) from Ancylostoma hookworms. Int J Parasitol 2005; 35: 303-313.
51. Gomis-Ruth FX, Maskos K, Betz M et al. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 1997; 389: 77-81.
52. Zhan B, Badamchian M, Meihua B et al. Molecular cloning and purification of Ac-TMP, a developmentally regulated putative tissue inhibitor of metalloprotease released in relative abundance by adult Ancylostoma hookworms. Am J Trop Med Hyg; 66: 238-244.
53. McKean PG & Pritchard DI. The action of a mast cell protease on the cuticular collagens of Necator americanus. Parasite Immunol 1989; 11: 293-297.
54. Green NM. Protease inhibitors from Ascaris lumbricoides. Biochem J 1957; 66: 416-419.
55. Peanasky RJ & Laskowski M. Chymotrypsin inhibitor from Ascaris. Biochim Biophys Acta 1960; 37: 167-169.
56. Peanasky RJ, Bentz Y, Paulson B, Graham DL & Babin DR. The isoinhibitors of chymotrypsin/elastase from Ascaris lumbricoides: isolation by affinity chromatography and association with the enzymes. Arch Biochem Biophys 1984; 232: 127-134.
57. Homandberg GA & Peanasky RJ. Characterization of proteins from Ascaris lumbricoides which bind specifically to carboxypeptidase. J Biol Chem 1976; 251: 2226-2233.
58. Abu-Erreish GM & Peanasky RJ. Pepsin inhibitors from Ascaris lumbricoides. Pepsin-inhibitor complex: stoichiometry of formation, dissociation, and stability of the complex. J Biol Chem 1974; 249: 1566-1571.
59. Hawley JH & Peanasky RJ. Ascaris suum: are trypsin inhibitors involved in species specificity of Ascarid nematodes? Exp Parasitol 1992; 75: 112-118.
60. Kassell B. Proteolytic enzyme inhibitors from Ascaris lumbricoides. Meth Enzymol 1970; 19: 872-883.
61. Ansari AA, Khan MA & Ghatak S. Ascaridia galli: Trypsin and chymotrypsin inhibitors. Exp Parasitol 1976; 39: 74-83.
62. Goodman RB, Martzen MR & Peanasky RJ. Trypsin inhibitors from Ascaris: the reactive P1 site of the inhibitors (a correction) and location of the inhibitors and host trypsin in cross-sections of Ascaris. Acta Biochim Pol 1983; 30: 233-244.
63. Martzen MR & Peanasky RJ. Ascaris suum: biosynthesis and isoinhibitor profile of chymotrypsin/elastase isoinhibitors. Exp Parasitol 1985; 59: 313-320.
64. Gronenborn AM, Nilges M, Peanasky RJ & Clore GM. Sequential resonance assignment and secondary structure determination of the Ascaris trypsin inhibitor, a member of a novel class of proteinase inhibitors. Biochemistry 1990; 29: 183-189.
65. Huang K, Strynadka NC, Bernard VD, Peanasky RJ & James MN. The molecular structure of the complex of Ascaris chymotrypsin/elastase inhibitor with porcine elastase. Structure 1994; 2: 679-689.
66. Bode W & Huber R. Natural protein proteinase inhibitors and their interaction with proteinases. Eur J Biochem 1992; 204: 433-451.
67. Lu CC, Nguyen T, Morris S, Hill D & Sakanari JA. Anisakis simplex: mutational bursts in the reactive site centers of serine protease inhibitors from an ascarid nematode. Exp Parasitol 1998; 89: 257-261.
68. Blanton RE, Licate LS & Aman RA. Characterization of a native and recombinant Schistosoma haematobium serine protease inhibitor gene product. Mol Biochem Parasitol 1994; 63: 1-11.
69. Modha J & Doenhoff MJ. Schistosoma mansoni host-parasite relationship: interaction of contrapsin with adult worms. Parasitology 1994; 109: 487-495.
70. Ford L, Guiliano DB, Oksov Y et al. Characterization of a novel filarial serine protease inhibitor, Ov-SPI-1, from Onchocerca volvulus, with potential multifunctional roles during development of the parasite. J Biol Chem 2005; 280: 40845-40856.
71. Johnson EH, Lustigman S, Kass PH, Irvine M, Browne J & Prince AM. Onchocerca volvulus: a comparative study of in vitro neutrophil killing of microfilariae and humoral responses in infected and endemic normals. Exp Parasitol 1995; 81: 9-19.
72. Gallin MY, Jacobi AB, Buttner DW, Schonberger O, Marti T & Erttmann KD. Human autoantibody to defensin: disease association with hyperreactive onchocerciasis (sowda). J Exp Med 1995; 182: 41-47.
73. Gutierrez-Pena EJ, Knab J & Buttner DW. Neutrophil granule proteins: evidence for the participation in the host reaction to skin microfilariae of Onchocerca volvulus after diethylcarbamazine administration. Parasitology 1996; 113: 403-414.
74. Loeb L & Smith AJ. The presence of a substance inhibiting the coagulation of blood in the Ancylostoma. Proc Pathol Soc Philadelphia 1904; 7: 173-178.
75. Thorson RE. The stimulation of acquired immunity in dogs by injections of extracts of the esophagus of adult hookworms. J Parasitol 1956; 42: 501-504.
76. Cappello M, Vlasuk GP, Bergum PW, Huang S & Hotez PJ. Ancylostoma caninum anticoagulant peptide: a hookworm-derived inhibitor of human coagulation factor Xa. Proc Natl Acad Sci USA 1995; 92: 6152-6156.
77. Stanssens P, Bergum PW, Gansemans Y et al. Anticoagulant repertoire of the hookworm Ancylostoma caninum. Proc Natl Acad Sci USA 1996; 93: 2149-2154.
78. Harrison LM, Cordova JL & Cappello M. Ancylostoma caninum anticoagulant peptide-5: immunolocalization and in vitro neutralization of a major hookworm anti-thrombotic. Mol Biochem Parasitol 2002; 115: 101-107.
79. Cappello M, Clyne LP, McPhedran P & Hotez PJ. Ancylostoma factor Xa inhibitor: partial purification and its identification as a major hookworm-derived anticoagulant in vitro. J Infect Dis 1993; 167: 1474-1477.
80. Mieszczanek J, Harrison LM, Vlasuk GP & Cappello M. Anticoagulant peptides from Ancylostoma caninum are immunologically distinct and localize to separate structures within the adult hookworm. Mol Biochem Parasitol 2004a; 133: 319-323.
81. Mieszczanek J, Harrison LM & Cappello M. Ancylostoma ceylanicum anticoagulant peptide-1: role of the predicted reactive site amino acid in mediating inhibition of coagulation factors Xa and VIIa. Mol Biochem Parasitol 2004b; 137: 151-159.
82. Vlasuk GP & Rote WE. Inhibition of factor VIIa/tissue factor with nematode anticoagulant protein c2: from unique mechanism to a promising new clinical anticoagulant. Trends Cardiovasc Med 2002; 12: 325-331.
83. Bernard VD & Peanasky RJ. The serine protease inhibitor family from Ascaris suum: chemical determination of the five disulfide bridges. Arch Biochem Biophys 1993; 303: 367-376.
84. Homandberg GA & Peanasky RJ. Characterization of proteins from Ascaris lumbricoides which bind specifically to carboxypeptidase. J Biol Chem 1976; 251: 2226-2233.
85. Macen JL, Upton C, Nation N & McFadden G. SERP1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation. Virology 1993; 195: 348-363.
86. McFadden G, Graham K, Ellison K et al. Interruption of cytokine networks by poxviruses: lessons from myxoma virus. J Leukoc Biol 1995; 57: 731-738.
87. Ray CA, Black RA, Kronheim SR et al. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell 1992; 69: 597-604.
88. Espagne E, Douris V, Lalmanach G et al. A virus essential for insect host-parasite interactions encodes cystatins. J Virol 2005; 79: 9765-9776.
89. Bryant P & Ploegh H. Class II MHC peptide loading by the professionals. Curr Opin Immunol 2004; 16: 96-102.
90. Burnett D, Abrahamson M, Devalia JL, Sapsford RJ, Davies RJ & Buttle DJ. Synthesis and secretion of procathepsin B and cystatin C by human bronchial epithelial cells in vitro: modulation of cathepsin B activity by neutrophil elastase. Arch Biochem Biophys 1995; 317: 305-310.
91. Maekawa Y, Himeno K, Ishikawa H et al. Switch of CD4+ T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis. J Immunol 1998; 161: 2120-2127.
92. Wiedow O & Meyer-Hoffert U. Neutrophil serine proteases: potential key regulators of cell signalling during inflammation. J Intern Med 2005; 257: 319-328.
93. Travis J. Structure, function, and control of neutrophil proteinases. Am J Med 1988; 84: 37-42.
94. Hase-Yamazaki T & Aoki Y. Stimulation of human lymphocytes by cathepsin G. Cell Immunol 1995; 160: 24-32.
95. Chertov O, Ueda H, Xu LL et al. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J Exp Med 1997; 186: 739-747.
96. Sambrano GR, Huang W, Faruqi T, Mahrus S, Craik C & Coughlin SR. Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem 2000; 275: 6819-6823.
97. Tsukuba T, Okamoto K, Yasuda Y, Morikawa W, Nakanishi H & Yamamoto K. New functional aspects of cathepsin D and cathepsin E. and . Mol Cells 2000; 10: 601-611.
98. Earnshaw WC, Martins LM & Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999; 68: 383-424.
99. Miller HR & Pemberton AD. Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology 2002; 105: 375-390.
100. Tani K, Ogushi F, Kido H et al. Chymase is a potent chemoattractant for human monocytes and neutrophils. J Leukoc Biol 2000; 67: 585-589.
101. Huang C, Friend DS, Qiu WT et al. Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6. J Immunol 1998; 160: 1910-1919.
102. Lutzelschwab C, Pejler G, Aveskogh M & Hellman L. Secretory granule proteases in rat mast cells. Cloning of 10 different serine proteases and a carboxypeptidase A from various rat mast cell populations. J Exp Med 1997; 185: 13-29.
103. Whitaker-Menezes D, Schechter NM & Murphy GF. Serine proteinases are regionally segregated within mast cell granules. Lab Invest 1995; 72: 34-41.
104. Steinhoff M, Buddenkotte J, Shpacovitch V et al. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 2005; 26: 1-43.
105. Gomez-Escobar N, Lewis E & Maizels RM. A novel member of the transforming growth factor-beta (TGF-beta) superfamily from the filarial nematodes Brugia malayi and B. pahangi. Exp Parasitol 1998; 88: 200-209.
106. Pastrana DV, Raghavan N, FitzGerald P et al. Filarial nematode parasites secrete a homologue of the human cytokine macrophage migration inhibitory factor. Infect Immun 1998; 66: 5955-5963.
107. Zang X, Taylor P, Wang JM et al. Homologues of human macrophage migration inhibitory factor from a parasitic nematode. Gene cloning, protein activity, and crystal structure. J Biol Chem 2002; 277: 44261-44267.
108. Harnett W, Goodridge HS & Harnett MM. Subversion of immune cell signal transduction pathways by the secreted filarial nematode product, ES-62. Parasitology 2005; 130 (Suppl.): S63-S68.
109. Hartmann S, Kyewski B, Sonnenburg B & Lucius R. A filarial cysteine protease inhibitor down-regulates T cell proliferation and enhances interleukin-10 production. Eur J Immunol 1997; 27: 2253-2260.
110. Rhoads ML, Fetterer RH, Hill DE & Urban JF Jr. Trichuris suis: a secretory chymotrypsin/elastase inhibitor with potential as an immunomodulator. Exp Parasitol 2000; 95: 36-44.
111. Lustigman S, Brotman B, Huima T, Prince AM & McKerrow JH. Molecular cloning and characterization of onchocystatin, a cysteine proteinase inhibitor of Onchocerca volvulus. J Biol Chem 1992; 267: 17339-17346.
112. Schönemeyer A, Lucius R, Sonnenburg B et al. Modulation of human T cell responses and macrophage functions by onchocystatin, a secreted protein of the filarial nematode Onchocerca volvulus. J Immunol 2001; 167: 3207-3215.
113. Pfaff AW, Schulz-Key H, Soboslay PT, Taylor DW, MacLennan K & Hoffmann WH. Litomosoides sigmodontis cystatin acts as an immunomodulator during experimental filariasis. Int J Parasitol 2002; 32: 171-178.
114. Watts C. Antigen processing in the endocytic compartment. Curr Opin Immunol 2001; 13: 26-31.
115. Dainichi T, Maekawa Y, Ishii K et al. Nippocystatin, a cysteine protease inhibitor from Nippostrongylus brasiliensis, inhibits antigen processing and modulates antigen-specific immune response. Infect Immun 2001; 69: 7380-7386.
116. Mahanty S, Mollis SN, Ravichandran M et al. High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis. J Infect Dis 1996; 173: 769-773.
117. Doetze A, Satoguina J, Burchard G et al. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift. Int Immunol 2000; 12: 623-630.
118. Verdot L, Lalmanach G, Vercruysse V et al. Cystatins upregulate nitric oxide release from interferon-gamma-activated mouse peritoneal macrophages. J Biol Chem 1996; 271: 28077-28081.
119. Hartmann S, Schonemeyer A, Sonnenburg B, Vray B & Lucius R. Cystatins of filarial nematodes up-regulate the nitric oxide production of interferon-gamma-activated murine macrophages. Parasite Immunol 2002; 24: 253-262.
120. O'Connor RA & Devaney E. Nitric oxide limits the expansion of antigen-specific T cells in mice infected with the microfilariae of Brugia pahangi. Infect Immun 2002; 70: 5997-6004.
121. Ichikawa K, Vailes LD, Pomes A & Chapman MD. Molecular cloning, expression and modelling of cat allergen, cystatin (Fel d 3), a cysteine protease inhibitor. Clin Exp Allergy 2001; 31: 1279-1786.
122. Hartmann S, Sollwedel A, Hoffmann A, Sonnenburg B & Lucius R. Characterization of IgE responses in a rodent model of filariasis and the allergenic potential of filarial antigens using an in vitro assay. Parasite Immunol 2003; 25: 9-16.
123. Plaisier AP, van Oortmarssen GJ, Remme J & Habbema JD. The reproductive lifespan of Onchocerca volvulus in West African savanna. Acta Trop 1991; 48: 271-284.
124. Potempa J, Korzus E & Travis J. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem 1994; 269: 15957-15960.
125. Zang X, Atmadja AK, Gray P et al. The serpin secreted by Brugia malayi microfilariae, Bm-SPN-2, elicits strong, but short-lived, immune responses in mice and humans. J Immunol 2000; 165: 5161-5169.
126. Jeannin P, Lecoanet-Henchoz S, Delneste Y, Gauchat JF & Bonnefoy JY. Alpha-1 antitrypsin up-regulates human B cell differentiation selectively into IgE- and IgG4-secreting cells. Eur J Immunol 1998; 28: 1815-1822.
127. Yenbutr P & Scott AL. Molecular cloning of a serine proteinase inhibitor from Brugia malayi. Infect Immun 1995; 63: 1745-1753.
128. Ghendler Y, Arnon R & Fishelson Z. Schistosoma mansoni: isolation and characterization of Smpi56, a novel serine protease inhibitor. Exp Parasitol 1994; 78: 121-131.
129. Johnson EH, Irvine M, Kass PH et al. Onchocerca volvulus: in vitro cytotoxic effects of human neutrophils and serum on third-stage larvae. Trop Med Parasitol 1994; 45: 331-335.
130. Gallin MY, Jacobi AB, Buttner DW, Schonberger O, Marti T & Erttmann KD. Human autoantibody to defensin: disease association with hyperreactive onchocerciasis (sowda). J Exp Med 1995; 182: 41-47.
131. Gutierrez-Pena EJ, Knab J & Buttner DW. Neutrophil granule proteins: evidence for the participation in the host reaction to skin microfilariae of Onchocerca volvulus after diethylcarbamazine administration. Parasitology 1996; 113: 403-414.
132. Wastling JM, Scudamore CL, Thornton EM, Newlands GF & Miller HR. Constitutive expression of mouse mast cell protease-1 in normal BALB/c mice and its up-regulation during intestinal nematode infection. Immunology 1997; 90: 308-313.
133. Mizutani H, Schechter N, Lazarus G, Black RA & Kupper TS. Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase. J Exp Med 1991; 174: 821-825.
134. Scudamore CL, Jepson MA, Hirst BH & Miller HR. The rat mucosal mast cell chymase, RMCP-II, alters epithelial cell monolayer permeability in association with altered distribution of the tight junction proteins ZO-1 and occludin. Eur J Cell Biol 1998; 75: 321-330.
135. He S & Walls AF. The induction of a prolonged increase in microvascular permeability by human mast cell chymase. Eur J Pharmacol 1998; 352: 91-98.
136. Rhoads ML, Fetterer RH & Hill DE. Trichuris suis: a secretory serine protease inhibitor. Exp Parasitol 2000; 94: 1-7.
137. Rhoads ML, Fetterer RH, Hill DE & Urban JF Jr. Trichuris suis: a secretory chymotrypsin/elastase inhibitor with potential as an immunomodulator. Exp Parasitol 2000; 95: 36-44.
138. Garraud O, Nkenfou C, Bradley JE, Perler FB & Nutman TB. Identification of recombinant filarial proteins capable of inducing polyclonal and antigen-specific IgE and IgG4 antibodies. J Immunol 1995; 155: 1316-1325.
139. Tume CB, Ngu JL, McKerrow JL et al. Characterization of a recombinant Onchocerca volvulus antigen (Ov33) produced in yeast. Am J Trop Med Hyg 1997; 57: 626-633.
140. Frank GR, Mondesire RR, Brandt KS & Wisnewski N. Antibody to the Dirofilaria immitis aspartyl protease inhibitor homologue is a diagnostic marker for feline heartworm infections. J Parasitol 1998; 84: 1231-1236.
141. Vercauteren I, Geldhof P, Peelaers I, Claerebout E, Berx G & Vercruysse J. Identification of excretory-secretory products of larval and adult Ostertagia ostertagi by immunoscreening of cDNA libraries. Mol Biochem Parasitol 2003; 126: 201-208.
142. Butler GS, Hutton M, Wattam BA et al. The specificity of TIMP-2 for matrix metalloproteinases can be modified by single amino acid mutations. J Biol Chem 1999; 274: 20391-20396.
143. Willenbrock F, Crabbe T, Slocombe PM et al. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A. Biochemistry 1993; 32: 4330-4337.
144. Parks WC, Wilson CL & Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004; 4: 617-629.
145. Stetler-Stevenson WG, Bersch N & Golde DW. Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity. FEBS Lett 1992; 296: 231-234.
146. Murphy AN, Unsworth EJ & Stetler-Stevenson WG. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol 1993; 157: 351-358.
147. Guedez L, Stetler-Stevenson WG, Wolff L et al. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest 1998; 102: 2002-2010.
148. Lim MS, Guedez L, Stetler-Stevenson WG & Stetler-Stevenson M. Tissue inhibitor of metalloproteinase-2 induces apoptosis in human T lymphocytes. Ann N Y Acad Sci 1999; 878: 522-523.
149. Yan Y, Liu S, Song G, Xu Y & Dissous C. Characterisation of a novel vaccine candidate and serine proteinase inhibitor from Schistosoma japonicum. Vet Parasitol 2005; 131: 53-60.
150. Newlands GF, Skuce PJ, Knox DP & Smith WD. Cloning and expression of cystatin, a potent cysteine protease inhibitor from the gut of Haemonchus contortus. Parasitology 2001; 122: 371-378.
151. Hotez PJ, Ashcom J, Bin Z et al. Effect of vaccinations with recombinant fusion proteins on Ancylostoma caninum habitat selection in the canine intestine. J Parasitol 2002; 88: 684-690.